Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6000
-0.0090 (-1.48%)
At close: Dec 5, 2025

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of 6.62 million. The enterprise value is 7.04 million.

Market Cap 6.62M
Enterprise Value 7.04M

Important Dates

The last earnings date was Wednesday, November 12, 2025.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

BCLI has 11.03 million shares outstanding. The number of shares has increased by 78.11% in one year.

Current Share Class 11.03M
Shares Outstanding 11.03M
Shares Change (YoY) +78.11%
Shares Change (QoQ) +27.70%
Owned by Insiders (%) 7.58%
Owned by Institutions (%) 0.02%
Float 10.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -0.86
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.65
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio 0.06
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -26.65

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -400.07%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 142.59%
Revenue Per Employee n/a
Profits Per Employee -471,565
Employee Count 27
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.19% in the last 52 weeks. The beta is 0.53, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change -63.19%
50-Day Moving Average 0.67
200-Day Moving Average 0.96
Relative Strength Index (RSI) 41.58
Average Volume (20 Days) 17,194

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 14.50

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -10.90M
Pretax Income -10.85M
Net Income -10.85M
EBITDA -10.69M
EBIT -10.90M
Earnings Per Share (EPS) -1.37
Full Income Statement

Balance Sheet

The company has 5,000 in cash and 427,000 in debt, giving a net cash position of -422,000 or -0.04 per share.

Cash & Cash Equivalents 5,000
Total Debt 427,000
Net Cash -422,000
Net Cash Per Share -0.04
Equity (Book Value) -7.69M
Book Value Per Share -0.70
Working Capital -8.52M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.28M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -78.11%
Shareholder Yield -78.11%
Earnings Yield -163.82%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667

Scores

Altman Z-Score n/a
Piotroski F-Score 2